Showing 9 posts of 9 posts found.


Celgene plays catch up with $1.4 billion immunotherapy deal

July 7, 2017
Medical Communications, Sales and Marketing BeiGene, Celgene, immunotherapy, pd-1

Those commentating on Celgene’s latest deal seem to be equally divided between two camps: it is too much money, too …


FDA shutters MSD’s Keytruda combination trials in myeloma

July 6, 2017
Medical Communications, Research and Development MSD, immunotherapy, keytruda, pd-1

Following on from the news last month that enrolment for Keytruda being used alongside Celgene’s Imnovid and Revlimid would have …

Keytruda image

MSD’s Keytruda impresses in lung cancer chemotherapy trial

December 21, 2015
Manufacturing and Production, Research and Development MSD, PD-L1, docetaxel, keytruda, lung cancer, non small cell lung cancer, non-small cell lung cancer, pd-1, pembrolizumab

MSD’s Keytruda significantly improved overall survival (OS) compared to chemotherapy in people with lung cancer and PD-L1 expression, a trial …

Regeneron building

Sanofi and Regeneron in immuno-oncology push

July 28, 2015
Manufacturing and Production, Research and Development Cancer, PD-1 inhibitors, Regeneron, Sanofi, collaboration, immuno-oncology, pd-1

Pharma giants Sanofi and Regeneron are extending the partnership that brought new heart drug Praluent to the market, with a …

Lung xray image

‘Postcode lottery’ still cause of many lung cancer deaths

December 3, 2014
Research and Development, Sales and Marketing DoH, Roche, astranzeneca, lung cancer, nlca, oncology, pd-1

Patients are still pointlessly dying of lung cancer due to a ‘postcode lottery’ of services according to new results from …

Merck surprise winner in PD-1 race

September 5, 2014
Medical Communications, Research and Development, Sales and Marketing Cancer, Merck, melanoma, pd-1

Merck has become the first company to bring a new class of cancer drug to the US market after the …


AZ shares climb on positive cancer drug news

September 1, 2014
Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, Pfizer, immunoc-oncology, pd-1

AstraZeneca has moved a key new oncology drug into mid-stage trials as it looks to shore up its cancer research …

Merck logo

Merck and Advaxis team up on immuno-oncology

August 26, 2014
Manufacturing and Production, Medical Communications, Research and Development ASCO, Merck, immunology, pd-1, pembrolizumab

Advaxis and Merck have signed a research deal to investigational Merck’s PD-1 inhibitor pembrolizumab in combination with Advaxis’ listeria-based cancer …

BMS image

BMS to make Opdivo submission

July 11, 2014
Sales and Marketing BMS, Cancer, EMA, FDA, ono, opdivo, pd-1

Bristol-Myers Squibb is to submit cancer treatment Opdivo to the US authorities after the drug received its first approval in …

Latest content